In EE-treated rats, we found extensive expression of CK19, which was an indicator of bile duct cell proliferation induced by cholestasis; however, these pathological changes were evidently reduced by KD or UDCA treatment (Figure 3B). The gene discussed is KRT19; the disease is cholestasis.